ENCLOMIPHENE

Sexual Function & LibidoResearch Only

Solid clinical evidence backs its effectiveness for testosterone restoration with 13 human studies demonstrating real-world results. The data quality surpasses most compounds in the research peptide space.

Primarily studied by reproductive endocrinologists and researchers investigating alternatives to traditional testosterone replacement therapy in hypogonadal men.

FDA Status
Compounding Allowed

Since Feb 2026

Evidence
Strong
Studies

30 total, 13 human

What is ENCLOMIPHENE?

This selective estrogen receptor modulator represents a cleaner approach to testosterone restoration compared to its parent compound clomiphene citrate. Male hormone researchers and fertility specialists study enclomiphene for its ability to boost natural testosterone production without the suppressive effects of direct hormone replacement. Unlike true peptides, this small molecule SERM offers a pharmaceutical-grade alternative to traditional testosterone therapy.

Enclomiphene works by occupying estrogen receptors in the brain's hypothalamus, tricking the body into thinking estrogen levels are low. This deception prompts the release of luteinizing hormone and follicle-stimulating hormone, which travel to the testes and stimulate natural testosterone production. The result is restored hormone levels through the body's own manufacturing process rather than external supplementation.

What the Research Shows

The 13 human studies include several well-designed clinical trials with measurable testosterone outcomes, representing unusually robust evidence for this research category.

Notable Studies

Reported Benefits

Testosterone restoration5 studies
Fertility support2 studies
Estrogen modulation
Endogenous hormone optimization2 studies

Regulatory Status

Compounding AllowedEffective: Feb 2026

Last verified: Feb 2026

Related Peptides

This information is for research purposes only and does not constitute medical advice. Always consult a licensed physician before using any peptides.